Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

14,477 total articles

Fiserv: Buying Into a Turnaround as Self-Inflicted Pain Clears the Deck

Fiserv: Buying Into a Turnaround as Self-Inflicted Pain Clears the Deck

Fiserv has engineered its own near-term volatility through leadership churn and a debt reshuffle, but the stock now trades at roughly 8.4x trailing earnings with $4.13B of free cash flow. For event-driven, value-seeking traders, that combination creates a high-expected-value long: enter around $50.45, stop at $47.00, target $60.00 over a primary mi…

Ride the Redemplo Momentum: A Mid-Term Trade Plan for ARWR

Ride the Redemplo Momentum: A Mid-Term Trade Plan for ARWR

Arrowhead Research Corporation's Redemplo SHTG readout cleared a high bar and the stock has ripped to a new 52-week high. The biotech now trades with elevated valuation and strong technical momentum. This trade idea lays out a mid-term (45 trading days) long with clear entry, stop and target while mapping catalysts and risks that could flip the the…

Buy Marvell on the AI Shakeout: Tactical Long with $285 Target

Buy Marvell on the AI Shakeout: Tactical Long with $285 Target

Marvell (MRVL) is a leading provider of custom silicon, networking and optical connectivity for AI data centers. With a market cap near $190.5B, low leverage and positive cash flow, the company can grow into its valuation if hyperscalers continue shifting spend to networking and custom ASICs. This trade idea outlines a mid-term (45 trading days) ta…

BioMarin: Commercial Muscle Behind the Next Rerating

BioMarin: Commercial Muscle Behind the Next Rerating

BioMarin's nine commercial therapies and strong free cash flow create a safety net that the market underappreciates. With positive VOXZOGO Phase 3 data and a clear path to an sNDA submission in Q3 2026, paired with a conservative balance sheet (about $2.8B cash) and $767M in free cash flow, BMRN looks positioned for a mid-term upside. This trade ta…

Buy the Relief Rally: Western Alliance Q2 Could Quiet Credit Anxiety

Buy the Relief Rally: Western Alliance Q2 Could Quiet Credit Anxiety

Western Alliance (WAL) looks positioned to see a near-term relief rally if Q2 results provide clarity on recent loan losses and CRE exposure. The bank trades at ~9x earnings and 1.15x book with a $8.8B market cap. This trade idea is a tactical long: enter near $79.00, stop at $72.00, target $92.00 over a 180-trading-day horizon, with clear risk man…

Regulatory Breakthrough and Booking Momentum Make WRAP a Tactical Buy

Regulatory Breakthrough and Booking Momentum Make WRAP a Tactical Buy

Wrap Technologies just cleared a large regulatory hurdle with an ATF ruling classifying the BolaWrap 150 as an instrument of restraint, not a firearm. That clarity shortens procurement cycles and opens federal, corrections, healthcare and international channels. With Q1 revenue up 45% YoY, $3.2M in bookings, and improved cash burn, the upgrade to a…

Buy the Dip: Bank OZK’s Diversification Push Justifies Near-Term Pain

Buy the Dip: Bank OZK’s Diversification Push Justifies Near-Term Pain

Bank OZK (OZK) is an inexpensive regional bank with a $5.75B market cap, a 3.43% yield and a multi-decade streak of dividend increases. Management is accelerating diversification across geographies and product lines; that will pressure near-term earnings but should improve long-term earnings stability. Take a long position with a clear entry, stop …

Telus: Oversold, High-Yield Setup for a 45-Day Bounce

Telus: Oversold, High-Yield Setup for a 45-Day Bounce

Telus (TU) looks like a tactical long: shares sit near the 52-week low at $9.95, offer an implied yield north of 11%, and show oversold technicals (RSI ~27) while short interest and short-volume activity remain elevated. This trade idea targets a mid-term bounce over 45 trading days with a defined entry, stop and target that balance income, mean-re…

Broadcom at New Highs: Why We're Still Buying Into Strength

Broadcom at New Highs: Why We're Still Buying Into Strength

Broadcom's combination of high-margin semiconductor franchises, recurring enterprise software, and dominant networking silicon positions it to capture AI infrastructure spend. The stock is expensive by conventional multiples, but strong free cash flow ($32.8B) and return on equity (33%) justify an accumulation strategy with strict stops. We lay out…